North America Dialysis Market is expected to reach USD 81.02 billion by 2030

The surge in diabetes and hypertension cases will propel the dialysis market during the forecast period.

North America Dialysis Market is valued at USD 64.38 billion in 2023, and is expected to reach USD 81.02 billion by 2030, with a CAGR of 3.3% from 2024 to 2030, according to new research by Next Move Strategy Consulting.

The escalating global incidence of Chronic Kidney Disease (CKD) serves as a prominent driver for the dialysis market. CKD, characterized by a gradual loss of kidney function over time, has witnessed a steady rise due to factors like aging populations, lifestyle-related conditions, and increased awareness leading to early diagnosis.

As CKD prevalence continues to grow, the demand for dialysis services, encompassing both haemodialysis and peritoneal dialysis, is experiencing a corresponding increase. This surge in demand positions the dialysis market at the forefront of addressing the healthcare needs of individuals grappling with CKD, driving market expansion and technological advancements to meet the rising treatment demand.

Moreover, the escalating global healthcare expenditure is a pivotal driver for the North America dialysis market, fostering increased investments in renal care infrastructure. As countries allocate substantial resources to enhance their healthcare systems, the expansion of dialysis services becomes a focal point.

This augmented financial commitment translates into improved accessibility to dialysis facilities, upgraded medical equipment, and enhanced patient care. The growing healthcare expenditure underscores a collective effort to address the rising prevalence of kidney-related ailments, further propelling the demand for dialysis treatments and positively impacting the overall market dynamics.

However, inherent risk of infections and complications associated with these procedures restrains the market growth. On the contrary, introduction of at-home dialysis solutions is creating growth opportunity for the market, where patients can conveniently use dialysis solutions at home.

This approach enhances patient comfort, reduces the need for frequent hospital visits, and provides a flexible kidney care option.

As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share.

By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to overall market growth.

Request a sample here: https://www.nextmsc.com/north-america-dialysis-market/request-sample

According to the report, leading players in the North America dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Insights from the North America Dialysis Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the North America dialysis market is provided in the report.

• The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

• The market share of the North America dialysis market and their competitive analysis are provided in the report.

Share this post?